STNM1 in human cancers: role, function and potential therapy sensitizer
Open Access
- 16 June 2023
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 109, 110775
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82003236, 82203377)
This publication has 188 references indexed in Scilit:
- Lentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivoJournal of Translational Medicine, 2013
- Stathmin 1 is a potential novel oncogene in melanomaOncogene, 2012
- Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomasGynecologic Oncology, 2011
- microRNA‐101 is a potent inhibitor of autophagyThe EMBO Journal, 2011
- Down-regulation of stathmin expression is required for megakaryocyte maturation and platelet productionBlood, 2011
- Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cellsBritish Journal of Cancer, 2010
- A Cohort Study of STMN1 Expression in Colorectal Cancer: Body Mass Index and PrognosisAmerican Journal of Gastroenterology, 2009
- Regulation of Microtubule Dynamic Instability in Vitro by Differentially Phosphorylated StathminJournal of Biological Chemistry, 2009
- Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activationProceedings of the National Academy of Sciences, 2009
- The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical studyBreast Cancer Research and Treatment, 2007